Impact of mass drug administration campaigns depends on interaction with seasonal human movement

International Health

Volumn 10, Issue 4, 2018, Pages 252-257

  Gerardin, Jaline ^a   Bertozzi Villa, Amelia ^a   Eckhoff, Philip A ^a   Wenger, Edward A ^a  

^a INSTITUTE FOR DISEASE MODELING   (United States)

Author keywords

Malaria; Mass drug administration; Mathematical modelling; Seasonal human movement

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MALARIA; MASS DRUG ADMINISTRATION; MATHEMATICAL MODEL; MIGRATION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH CAMPAIGN; SEASONAL VARIATION; SIMULATION; TRAVEL; PROGRAM EVALUATION; SEASON; STATISTICS AND NUMERICAL DATA; THEORETICAL MODEL; TRANSMISSION;

MALARIA VACCINE;

HUMAN MIGRATION; HUMANS; MALARIA; MALARIA VACCINES; MASS DRUG ADMINISTRATION; MODELS, THEORETICAL; PROGRAM EVALUATION; SEASONS;

EID: 85050242788     PISSN: 18763413     EISSN: 18763405     Source Type: Journal    
DOI: 10.1093/inthealth/ihy025     Document Type: Article

References (27)

1. Smits HL. Prospects for the control of neglected tropical diseases by mass drug administration. Expert Rev Anti Infect Ther 2014;7(1):37-56
2. World Health Organization. Guidelines for the treatment of malaria, 3rd ed. Geneva: World Health Organization, 2015
3. Griffin JT. The interaction between seasonality and pulsed interventions against malaria in their effects on the reproduction number. PLoS Comput Biol 2015;11(1):e1004057
4. Gu W, Killeen GF, Mbogo CM et al. An individual-based model of Plasmodium falciparum malaria transmission on the coast of Kenya. Trans R Soc Trop Med Hyg 2003;97(1):43-50
5. Kajeechiwa L, Thwin MM, Shee PW et al. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border. Malar J 2016;15:494
6. von Seidlein L, Walraven G, Milligan PJ et al. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg 2003;97(2):217-25
7. Peto T, Tripura R, von Seidlein L. Model citizen. Lancet Glob Health 2017;5(1):e973
8. Kajeechiwa L, Thwin MM, Nosten S et al. Community engagement for the rapid elimination of malaria: the case of Kayin State, Myanmar. Wellcome Open Res 2017;2:59
9. Dial NJ, Ceesay SJ, Gosling RD et al. A qualitative study to assess community barriers to malaria mass drug administration trials in the Gambia. Malar J 2014;13:47
10. Dierickx S, Gryseels C, Mwesigwa J et al. Factors associated with nonparticipation and non-adherence in directly observed mass drug administration for malaria in The Gambia. PLoS One 2016;11(2):e0148627
11. Landier J, Kajeechiwa L, Thwin MM et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisininresistant falciparum malaria: a pilot trial in four villages of Eastern Myanmar. Wellcome Open Res 2017;2:81
12. Brady OJ, Slater HC, Pemberton-Ross P et al. Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study. Lancet Glob Health 2017:5(7):e680-7
13. Gerardin J, EckhoffP, Wenger EA. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination. BMC Infect Dis 2015;15:144
14. Okell LC, Drakeley CJ, Bousema T et al. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med 2008;5(11):e226
15. Maude RJ, Socheat D, Nguon C et al. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. PLoS One 2012;7(5):e37166
16. Crowell V, Briët OJT, Hardy D et al. Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden. Malar J 2013;12:4
17. Somboon P, Aramrattana A, Lines J et al. Entomological and epidemiological investigations of malaria transmission in relation to population movements in forest areas of north-west Thailand. Southeast Asian J Trop Med Public Health 1998;29(1):3-9
18. Parker DM, Landier J, von Seidlein L et al. Limitations of malaria reactive case detection in an area of low and unstable transmission on the Myanmar-Thailand border. Malar J 2016;15:571
19. Institute for Disease Modeling. Epidemiological modeling software. www.idmod.org/software [accessed 1 August 2017]
20. EckhoffP. Mathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settings. Am J Trop Med Hyg 2013;88(5):817-27
21. Gerardin J, Ouédraogo AL, McCarthy KA et al. Characterization of the infectious reservoir of malaria with an agent-based model calibrated to age-stratified parasite densities and infectiousness. Malar J 2015; 14:231
22. EckhoffPA. A malaria transmission-directed model of mosquito life cycle and ecology. Malar J 2011;10:303
23. Malaria Policy Advisory Committee. Evidence Review Group on MDA, MSAT and FSAT. Geneva: World Health Organization, 2015
24. Marshall JM, Touré M, Ouédraogo AL et al. Key traveller groups of relevance to spatial malaria transmission: a survey of movement patterns in four sub-Saharan African countries. Malar J 2016;15:200
25. Bousema T, Griffin JT, Sauerwein RW et al. Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med 2012;9 (1):e1001165
26. Bousema T, Stresman G, Baidjoe AY et al. The impact of hotspottargeted interventions on malaria transmission in Rachuonyo South District in the western Kenyan highlands: a cluster-randomized controlled trial. PLoS Med 2016;13(4):e1001993
27. Gerardin J, Bever CA, Bridenbecker D et al. Effectiveness of reactive case detection for malaria elimination in three archetypical transmission settings: a modelling study. Malar J 2017;16:248